好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Irinotecan/Bevacizumab for the Treatment of Refractory Brain Metastases in Patients with Her2-Neu Positive Breast Cancer
Neuro-oncology
(-)
012
Authors/Disclosures
Soma Sengupta, MD, PhD, FAAN (Tufts Medical Center) Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Novocure. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Bioventures. Dr. Sengupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bexion. Dr. Sengupta has stock in Amlal. The institution of Dr. Sengupta has received research support from ABTA. Dr. Sengupta has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Suriya A. Jeyapalan, MD, MPH (Tufts Medical Center) Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure.
No disclosure on file
Marcelo C. Kremenchutzky, MD, FAAN (Lhsc - UWO) No disclosure on file